May 12 (Reuters) - scPharmaceuticals Inc SCPH.O :
* SCPHARMACEUTICALS INC. REPORTS FIRST QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* SCPHARMACEUTICALS INC - FREEDOM CLINICAL STUDY ON TRACK
FOR
TOPLINE RESULTS IN Q3 2021
* SCPHARMACEUTICALS INC - ENDED Q1 WITH CASH, CASH
EQUIVALENTS,
RESTRICTED CASH AND INVESTMENTS OF $96.5 MILLION
* SCPHARMACEUTICALS INC - BELIEVES ITS CASH, CASH
EQUIVALENTS,
RESTRICTED CASH AND INVESTMENTS ARE SUFFICIENT TO FUND
OPERATIONS INTO 2023
* SCPHARMACEUTICALS INC - NET LOSS OF $7.1 MILLION FOR Q1 OF
2021,
COMPARED TO $7.1 MILLION FOR COMPARABLE PERIOD IN 2020
Source text for Eikon: ID:nGNX3MSvJ6
Further company coverage: SCPH.O
((reuters.briefs@thomsonreuters.com;))